Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Robert Superko

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of the American College of Cardiology|March 20, 2010
Statins in acute coronary syndromes and genetic insightH Robert Superko, Kathryn Momary, Spencer King
American Journal of Preventive Cardiology|June 12, 2025
The aspirin heart disease prevention conundrumH Robert Superko, John Sninsky, Brenda Garrett
The Medical Clinics of North America|March 7, 2012
Statins personalizedH Robert Superko, Kathryn M Momary, Yonghong Li
The American Journal of Cardiology|September 3, 2004
Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or IH Robert Superko, Mark E McGovern, Elaine Raul, et al.
Clinical Cardiology|November 17, 2018
Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelinesH Robert Superko, Paul T Williams, Michael Dansinger, et al.
Clinical Cardiology|December 25, 2010
Family coronary heart disease: a call to actionH Robert Superko, Robert Roberts, Brenda Garrett, et al.
Current Atherosclerosis Reports|December 3, 2013
Genetics and personalized medicine--a role in statin therapy?Jaideep Patel, Thura Abd, Roger S Blumenthal, et al.
Preventive Medicine|February 12, 2019
The importance of cholesterol follow-up testing under current statin treatment guidelinesMichael L Dansinger, Paul T Williams, H Robert Superko, et al.
Lipids in Health and Disease|July 18, 2019
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factorsMichael L Dansinger, Paul T Williams, H Robert Superko, et al.
Circulation|November 6, 2013
Omega-3 fatty acid blood levels: clinical significance and controversyH Robert Superko, Scott M Superko, Khurram Nasir, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of the American College of Cardiology|March 20, 2010
Statins in acute coronary syndromes and genetic insightH Robert Superko, Kathryn Momary, Spencer King
American Journal of Preventive Cardiology|June 12, 2025
The aspirin heart disease prevention conundrumH Robert Superko, John Sninsky, Brenda Garrett
The Medical Clinics of North America|March 7, 2012
Statins personalizedH Robert Superko, Kathryn M Momary, Yonghong Li
The American Journal of Cardiology|September 3, 2004
Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or IH Robert Superko, Mark E McGovern, Elaine Raul, et al.
Clinical Cardiology|November 17, 2018
Trends in low-density lipoprotein-cholesterol blood values between 2012 and 2017 suggest sluggish adoption of the recent 2013 treatment guidelinesH Robert Superko, Paul T Williams, Michael Dansinger, et al.
Clinical Cardiology|December 25, 2010
Family coronary heart disease: a call to actionH Robert Superko, Robert Roberts, Brenda Garrett, et al.
Current Atherosclerosis Reports|December 3, 2013
Genetics and personalized medicine--a role in statin therapy?Jaideep Patel, Thura Abd, Roger S Blumenthal, et al.
Preventive Medicine|February 12, 2019
The importance of cholesterol follow-up testing under current statin treatment guidelinesMichael L Dansinger, Paul T Williams, H Robert Superko, et al.
Lipids in Health and Disease|July 18, 2019
Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factorsMichael L Dansinger, Paul T Williams, H Robert Superko, et al.
Circulation|November 6, 2013
Omega-3 fatty acid blood levels: clinical significance and controversyH Robert Superko, Scott M Superko, Khurram Nasir, et al.
Pageof 4